Infectious, Oncologic, and Autoimmune Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting

被引：7

作者：

Armstrong, April W. ^{[1
]}

Coates, Laura C. ^{[2
,3
]}

Espinoza, Luis R. ^{[4
]}

Ogdie, Alexis R. ^{[5
]}

Rich, Phoebe ^{[6
]}

Soriano, Enrique R. ^{[7
]}

机构：

[1] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95816 USA

[2] Univ Leeds, Leeds Inst Mol Med, Div Rheumat & Musculoskeletal Dis, Leeds, W Yorkshire, England

[3] NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England

[4] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA

[5] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA

[6] Oregon Dermatol & Res Ctr, Portland, OR USA

[7] Hosp Italiano Buenos Aires, Rheumatol Unit, Buenos Aires, DF, Argentina

来源：

JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 08期

关键词：

PSORIASIS; PSORIATIC ARTHRITIS; COMORBIDITIES; INFECTION; MALIGNANCY; AUTOIMMUNE; HEPATITIS-C VIRUS; POPULATION-BASED COHORT; ETANERCEPT THERAPY; ATOPIC-DERMATITIS; PHASE-III; A THERAPY; PREVALENCE; DISEASE; RISK; PATIENT;

D O I：

10.3899/jrheum.130458

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and PsA (GRAPPA) in Stockholm, Sweden, members addressed the infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis (PsA). Members discussing infectious comorbidities asked whether patients with psoriasis or PsA are predisposed to particular types of infections, and whether the use of biologic agents is advisable in patients with certain preexisting infections. Regarding the oncologic comorbidities of psoriasis and PsA, members addressed cutaneous malignancy screening, lymphoproliferative malignancy risk and the need for screening, and treatment of patients with preexisting oncologic history requiring systemic therapy. Finally, GRAPPA members discussed autoimmune comorbidities associated with psoriasis and PsA; they agreed that research is nascent in this field and larger studies are necessary to determine the precise magnitude of these associations.

引用

页码：1438 / 1441

页数：4

共 42 条

[21] Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis [J].

Mederacke, Ingmar ;

Witte, Torsten ;

Wedemeyer, Heiner ;

Meyer-Olson, Dirk .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) :1343-U192

[22] Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics [J].

Menter, Alan ;

Gottlieb, Alice ;

Feldman, Steven R. ;

Van Voorhees, Abby S. ;

Leonardi, Craig L. ;

Gordon, Kenneth B. ;

Lebwohl, Mark ;

Koo, John Y. M. ;

Elmets, Craig A. ;

Korman, Neil J. ;

Beutner, Karl R. ;

Bhushan, Reva .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (05) :826-850

[23] Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial [J].

Menter, Alan ;

Tyring, Stephen K. ;

Gordon, Kenneth ;

Kimball, Alexa B. ;

Leonardi, Craig L. ;

Langley, Richard G. ;

Strober, Bruce E. ;

Kaul, Martin ;

Gu, Yihua ;

Okun, Martin ;

Papp, Kim .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (01) :106-115

[24] Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet [J].

Michaëlsson, G ;

Gerdén, B ;

Hagforsen, E ;

Nilsson, B ;

Pihl-Lundin, I ;

Kraaz, W ;

Hjelmquist, G ;

Lööf, L .

BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) :44-51

[25] Hepatitis C virus and arthritis [J].

Olivieri, I ;

Palazzi, C ;

Padula, A .

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (01) :111-+

[26] Hepatitis C virus infection in psoriatic arthritis [J].

Palazzi, C ;

Olivieri, I ;

D'Amico, E ;

D'Agostino, L ;

Nicolucci, A ;

Pennese, E ;

Petricca, A .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (02) :223-225

[27] Transcriptional regulation of the elafin gene in human keratinocytes [J].

Pol, A ;

Pfundt, R ;

Zeeuwen, P ;

Molhuizen, H ;

Schalkwijk, J .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) :301-307

[28] Hepatitis C virus RNA profiles in chronically infected individuals: Do they relate to disease activity? [J].

Pontisso, P ;

Bellati, G ;

Brunetto, M ;

Chemello, L ;

Colloredo, G ;

Di Stefano, R ;

Nicoletti, M ;

Rumi, MG ;

Ruvoletto, MG ;

Soffredini, R ;

Valenza, LM ;

Colucci, G .

HEPATOLOGY, 1999, 29 (02) :585-589

[29] Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance [J].

Prignano, Francesca ;

Ricceri, Federica ;

Pescitelli, Leonardo ;

Bonciani, Diletta ;

Lotti, Torello .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (08) :999-1001

[30] Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial [J].

Reich, K ;

Nestle, FO ;

Papp, K ;

Ortonne, JP ;

Evans, R ;

Guzzo, C ;

Li, S ;

Dooley, LT ;

Griffiths, CEM .

LANCET, 2005, 366 (9494) :1367-1374

← 1 2 3 4 5 →